GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 39 filers reported holding GALERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $926 | -86.8% | 5,288 | +135.0% | 0.00% | – |
| Q2 2023 | $7,020 | +28.0% | 2,250 | +5.0% | 0.00% | – |
| Q1 2023 | $5,484 | +72.0% | 2,142 | +0.1% | 0.00% | – |
| Q4 2022 | $3,189 | +6.3% | 2,140 | +0.6% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 2,128 | +3.2% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 2,063 | +0.3% | 0.00% | – |
| Q1 2022 | $5,000 | -44.4% | 2,057 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | -65.4% | 2,057 | -36.8% | 0.00% | – |
| Q3 2021 | $26,000 | -18.8% | 3,254 | -0.1% | 0.00% | – |
| Q2 2021 | $32,000 | -78.7% | 3,257 | -80.9% | 0.00% | – |
| Q1 2021 | $150,000 | -57.6% | 17,012 | -50.8% | 0.00% | – |
| Q4 2020 | $354,000 | +471.0% | 34,611 | +407.9% | 0.00% | – |
| Q3 2020 | $62,000 | -46.6% | 6,815 | -58.0% | 0.00% | – |
| Q2 2020 | $116,000 | +132.0% | 16,218 | +206.9% | 0.00% | – |
| Q1 2020 | $50,000 | +2400.0% | 5,285 | +3757.7% | 0.00% | – |
| Q4 2019 | $2,000 | – | 137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $2,815,000 | 0.83% |
| Sofinnova Investments, Inc. | 3,083,712 | $14,154,000 | 0.83% |
| Novo Holdings A/S | 2,459,021 | $11,287,000 | 0.53% |
| ACUTA CAPITAL PARTNERS, LLC | 262,500 | $1,205,000 | 0.51% |
| Tekla Capital Management LLC | 898,374 | $4,124,000 | 0.13% |
| Aristides Capital LLC | 20,000 | $92,000 | 0.04% |
| XTX Topco Ltd | 13,499 | $62,000 | 0.04% |
| Blackstone Inc. | 1,678,984 | $7,707,000 | 0.02% |
| Taylor Wealth Management Partners | 11,635 | $53,000 | 0.02% |
| Belvedere Trading LLC | 96,486 | $255,000 | 0.01% |